Company / Goodwill
Summit Therapeutics Inc. Goodwill History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$2.0M
FY2025
5-year range
$1.8M / $2.0M
FY2021-FY2025
Trend
+7.3%
vs FY2024
Sector context
#66 of 74
Health Care
What the data says
Summit Therapeutics Inc.'s goodwill of $2M is lower than 89% of companies in the Health Care sector (FY2025). Goodwill has fluctuated over the past 8 years, ranging from $2M in FY2022 to $2M in FY2020.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -0.3%.
Improved from $2M to $2M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 74This company $2.0M Sector average $4.0B
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.3%, indicating a declining trend.
- In FY2025, goodwill increased 7.3% year-over-year.
- Ranks #66 out of 74 companies in the Health Care sector.
- Peak goodwill was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0M | +7.3% |
| FY2024 | $1.9M | -1.5% |
| FY2023 | $1.9M | +5.3% |
| FY2022 | $1.8M | -10.5% |
| FY2021 | $2.0M | -1.0% |
| FY2020 | $2.0M | +3.5% |
| FY2019 | $2.0M | +0.5% |
| FY2018 | $2.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026